MarketsStocksBAFNAPH
BA

Bafna Pharmaceuticals Ltd

NSE: BAFNAPHBSE: 532989Healthcare
Download Research Report7-page PDF
193.97
+10.00%
NSE · auto-updates while market open
Prev Close
₹73.93
Day High
₹193.97
Day Low
₹187.35
Mkt Cap
₹505 Cr
P / E
45.5
P / B
5.3
ROE
12.3%
52W High
₹202.06
52W Low
₹72.01
Key Metrics
Market Cap
₹505 Cr
P / E
45.47
P / B
5.25
EV / EBITDA
28.38
ROCE
11.9%
ROE
12.3%
Debt / Equity
0.39
Book Value
₹40.64
EPS
₹4.69
Div Yield
0.0%
Face Value
₹10
Promoter Holding
75.0%
Revenue · ₹ Cr
42
FY20
71
FY21
85
FY22
115
FY23
152
FY24
146
FY25
151
FY26
Net Profit · ₹ Cr
6
5
11
7
4
11
-25
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹2.5
₹4.3
₹4.9
₹3.1
₹1.8
₹4.7
₹-15.5
FY20FY21FY22FY23FY24FY25FY26
P / E Ratio · price ÷ TTM EPS
74481119630-0Jun 21Feb 23Oct 24Jun 26
P/E 41.4×Median 27.2×TTM EPS
Q1 2020 snapshot
Sales
₹13 Cr
Operating profit
₹3 Cr
OPM
25.9%
Net profit
₹0 Cr
EPS
₹0.20
Scorecard · 7 axes
Quality
Strong
75/100
Valuation
Weak
45.5×
Growth
Good
+18.2%
Profitability
Avg
12.1%
Performance
Strong
+136.7%
Entry Point
Bad
96%
Red Flags
Strong
0 flags
Shareholding Pattern
75.0%Promoter
Promoter75.0%
FII9.3%
Public15.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue33.3840.0935.2236.6539.5144
Net Profit0.9481.3113.3893.1251.8372.749
NPM %2.8%3.3%9.6%8.5%4.6%6.2%
AlertPre-trade